Clinical Trial Update: A Trial to Evaluate the Safety, Tolerability and Preliminary Efficacy of NCR201 in the Treatment of Subjects With Parkinson's Disease [Phase 1]

View source ↗

Summary

This update describes a Phase 1 study evaluating the safety, tolerability, and preliminary efficacy of NCR201 in Parkinson disease; the trial is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• NCR201

Snippet

Sponsor: Nuwacell Biotechnologies Co., Ltd. | Conditions: Parkinson Disease | Phase 1 | Status: RECRUITING